Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke

Inger de Ridder, Maaike Dirks, Louis Niessen, Diederik Dippel, PRACTISE Investigators

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

A recent meta-analysis showed that women with acute ischemic stroke are less likely to receive treatment with intravenous alteplase than men. The aim of this study was to assess sex differences in treatment with intravenous alteplase and to explore the reasons for these differences.
Original languageEnglish
Pages (from-to)2610-2
Number of pages3
JournalStroke
Volume44
Issue number9
DOIs
Publication statusPublished - Sep 2013

Keywords

  • Administration, Intravenous
  • Aged
  • Aged, 80 and over
  • Brain Ischemia
  • Clinical Trials as Topic
  • Female
  • Fibrinolytic Agents
  • Health Services Accessibility
  • Humans
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Sex Factors
  • Stroke
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator
  • Treatment Outcome

Cite this